Xtx Topco LTD Revolution Medicines, Inc. Transaction History

Xtx Topco LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$30.14 - $40.68 $714,830 - $964,807	23,717 New	23,717 $920,000
Q3 2023 Nov 13, 2023	BUY	$25.17 - $35.05 $162,573 - $226,387	6,459 Added 50.92%	19,143 $529,000
Q2 2023 Aug 14, 2023	BUY	$20.28 - $27.0 $55,100 - $73,359	2,717 Added 27.26%	12,684 $339,000
Q1 2023 May 12, 2023	SELL	$20.76 - $30.09 $3,176 - $4,603	-153 Reduced 1.51%	9,967 $215,000
Q4 2022 Feb 14, 2023	BUY	$17.68 - $25.53 $178,921 - $258,363	10,120 New	10,120 $241,000

266

161M

260K

620K

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.8B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.